AIDS-related Funding Opportunity Announcements (FOAs)

NIMH FOAs

Notice of Special Interest (NOSI)

NOT-MH-20-013: Notice of Special Interest (NOSI): Mental Health Comorbidities in HIV Prevention and Treatment

NOT-MH-20-019: Notice of Special Interest (NOSI): Strengthening the HIV Prevention Continuum

NOT-MH-20-020: Notice of Special Interest: Stigma or Other Social Determinants of Health (SDOH) in HIV Prevention and Treatment

NOT-MH-20-023: Notice of Special Interest (NOSI): Strengthening the HIV Care Continuum

NOT-MH-20-024: Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets

NOT-MH-20-035: Notice of Special Interest (NOSI): Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults

NOT-MH-21-105: Notice of Special Interest (NOSI): Advancing Health Communication Research on HIV Prevention, Treatment and Cure

NOT-MH-22-095: Notice of Special Interest (NOSI): NIMH Priorities on Research on Aggression and Violence Against Others

NOT-MH-23-100: Notice of Data Sharing Policy for the National Institute of Mental Health

Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR)

PAR-20-149: HIV Infection of the Central Nervous System (R01 Clinical Trial Not Allowed)

PAR-20-151: Eradication of HIV-1 from Central Nervous system Reservoirs (R01 Clinical Trial Not Allowed)

PAR-20-307: Developmental AIDS Research Centers on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)

PAR-20-308: AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)

PAR-21-228: NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25 Clinical Trial Not Allowed)

PAR-23-060: Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)

PAR-23-061: Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Option)

PAR-23-062: Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Option)

---

Co-Sponsored FOAs

Request for Applications (RFA)

RFA-AI-20-076: New Technologies for the In vivo Delivery of Gene Therapeutics for an HIV Cure (R01 Clinical Trial Not Allowed)

RFA-HD-24-006: Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)

Notice of Special Interest (NOSI)

NOT-AI-21-011: Notice of Special Interest (NOSI): Secondary Analysis of Existing Datasets for Advancing Immune-mediated and Infectious Disease Research

NOT-AI-21-054: Notice of Special Interest (NOSI): Harnessing Big Data to Halt HIV

NOT-AI-21-057: Notice of Special Interest (NOSI) HIV/AIDS in the Era of COVID-19: When Pandemics Collide

NOT-AI-22-042 Notice of Special Interest (NOSI): Sustained Release of Antivirals for Treatment or Prevention of HIV or Treatment of Latent TB/HBV (SRATP)

NOT-AI-22-056 Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation

NOT-AI-22-072: Notice of Special Interest (NOSI): Opportunities for HIV Cure Interventions at the Time of ART Initiation

NOT-AI-23-016: Notice of Special Interest (NOSI): Administrative Supplements to NIH Centers for AIDS Research (CFAR) and NIMH AIDS Research Centers (ARC) for Ending the HIV Epidemic (EHE)

NOT-CA-22-037: Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research

NOT-DA-21-060: Notice of Special Interest (NOSI): Reducing Stigma Related to Drug Use in Human Service Settings

NOT-OD-21-100: Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health

Program Announcement with Special Receipt, Referral, and/or Review Considerations (PAR)

PAR-21-068: Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

PAR-21-070: Detection of HIV for Self-Testing (R61/R33 Clinical Trial Not Allowed)

PAR-21-297: Multipurpose Prevention Technology: Novel Systemic Options for Young Adults

PAR-22-151: Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)

PAR-22-152: Planning Grant for Fogarty HIV Research Training Program for Low- and Middle-Income Country Institutions (D71 Clinical Trial Not Allowed)

PAR-22-248: HIV/AIDS Scholars Using Nonhuman Primate (NHP) Models Program (K01 Independent Clinical Trial Not Allowed)

PAR-22-252: Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)